Yes, and it’s reasonable to think that this acceleration is down to the growth of the sales team and improving access to hospitals and clinicians with the lessening of Covid impacts. Covid remains into the future but, fingers crossed, its worst effects look to be behind us. So, if the co continues to grow the sales team aggressively the acceleration in account acquisition should continue.
Ann: FY22 Results Presentation, page-429
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 232 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 3934 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |